Elsevier Inc.

SHERPA: Unknown

People

  1. Devlin
    Devlin
  2. Scordo
    Scordo
  3. Shah
    Shah
  4. Giralt
    Giralt
  5. Perales
    Perales
  6. Dahi
    Dahi
  7. Gyurkocza
    Gyurkocza
  8. Tamari
    Tamari
  9. Jakubowski
    Jakubowski
  10. Papadopoulos
    Papadopoulos

Groups

  1. Biostatistics Service (41)
  2. Bone Marrow Transplant (41)
  3. CTCR Scholars (41)
  4. Center for Hematologic Malignancies (41)
  5. Department of Medicine (41)
  6. Epidemiology and Biostatistics (41)
  7. Hematologic Malignancies, Division of (41)
  8. Survivorship Research (39)
  9. MSK Grad Students (34)
  10. Master of Science in Clinical and Translational Cancer Research (33)
Search Within
  1. "Bone Marrow Transplant"
  2. "Sean Devlin"
  3. "Michael Scordo"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (12)
Groups
  1. Biostatistics Service (41)
  2. Bone Marrow Transplant (41)
  3. CTCR Scholars (41)
  4. Center for Hematologic Malignancies (41)
  5. Department of Medicine (41)
  6. Epidemiology and Biostatistics (41)

More Groups

People
  1. Michael Scordo (41)
  2. Sean Devlin (41)
  3. Gunjan Shah (39)
  4. Sergio Giralt (38)
  5. Miguel-Angel Perales (30)
  6. Parastoo Dahi (24)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (13)
  6. 2019 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (26)
  2. Transplantation and Cellular Therapy (8)
  3. Clinical Lymphoma, Myeloma and Leukemia (6)
  4. International Journal of Radiation Oncology, Biology, Physics (1)

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Nath, K.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Pilot trial of homebound hematopoietic cell transplantation
    Journal Article

    Landau, H. J.; Orlando, E.; Rodriguez, E. S.; Applebaum, A.; Mitchell, H. R.; Peled, J. U.; Khan, N.; Funnell, T.; Chung, D.; Scordo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save